Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JimaTong Tablet for Stage 1 Hypertension (Liver-Fire Hyperactivity Pattern)
CTR20131805Phase 2Completed
- Sponsor
- Zhejiang Chinese Medical University
- Start
- May 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JimaTong Tablet in essential hypertension, sponsored by Zhejiang Chinese Medical University. Started May 2014; status: completed.
02
Drugs
JimaTong Tablet
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20131805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131805.